Nanovibronix Shares Outstanding 2014-2019 | NAOV
Nanovibronix shares outstanding from 2014 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Nanovibronix Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2018 | 6 |
| 2017 | 5 |
| 2016 | 5 |
| 2015 | 4 |
| 2014 | 0 |
| 2013 | 0 |
| Nanovibronix Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q1 2019 | 7 |
| Q4 2018 | 6 |
| Q3 2018 | 6 |
| Q2 2018 | 6 |
| Q1 2018 | 6 |
| Q4 2017 | 5 |
| Q3 2017 | 5 |
| Q2 2017 | 5 |
| Q1 2017 | 5 |
| Q4 2016 | 5 |
| Q3 2016 | 5 |
| Q2 2016 | 5 |
| Q1 2016 | 5 |
| Q4 2015 | 4 |
| Q3 2015 | 5 |
| Q2 2015 | 4 |
| Q1 2015 | 0 |
| Q4 2014 | 0 |
| Q3 2014 | 0 |
| Q2 2014 | 0 |
| Q1 2014 | 0 |
| Q4 2013 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.012B | $0.000B |
| NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $115.922B | 25.36 |
| Intuitive Surgical (ISRG) | United States | $61.051B | 53.31 |
| Edwards Lifesciences (EW) | United States | $40.518B | 40.49 |
| IDEXX Laboratories (IDXX) | United States | $24.496B | 64.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.093B | 15.17 |
| Teleflex (TFX) | United States | $15.464B | 33.50 |
| Olympus (OCPNY) | Japan | $15.120B | 113.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.591B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.533B | 39.18 |
| DexCom (DXCM) | United States | $13.892B | 272.46 |
| Hologic (HOLX) | United States | $12.939B | 20.81 |
| STERIS (STE) | Ireland | $12.366B | 29.91 |
| Varian Medical Systems (VAR) | United States | $12.078B | 30.81 |
| ABIOMED (ABMD) | United States | $11.795B | 71.75 |
| Masimo (MASI) | United States | $8.182B | 50.13 |
| Penumbra (PEN) | United States | $6.119B | 259.03 |
| SARTORIUS AG (SARTF) | Germany | $5.850B | 51.98 |
| Elekta AB (EKTAY) | Sweden | $5.087B | 38.33 |
| Integra LifeSciences Holdings (IART) | United States | $4.653B | 21.86 |
| Globus Medical (GMED) | United States | $4.220B | 26.31 |
| Tandem Diabetes Care (TNDM) | United States | $3.752B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.543B | 23.09 |
| Wright Medical Group (WMGI) | Netherlands | $3.423B | 678.50 |
| Cantel Medical (CMD) | United States | $3.306B | 33.54 |
| Glaukos (GKOS) | United States | $2.735B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.652B | 19.54 |
| Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.903B | 30.11 |
| Nevro (NVRO) | United States | $1.882B | 0.00 |
| Inogen (INGN) | United States | $1.287B | 28.48 |
| Silk Road Medical (SILK) | United States | $1.279B | 0.00 |
| OPKO Health (OPK) | United States | $1.274B | 0.00 |
| Veracyte (VCYT) | United States | $1.243B | 0.00 |
| CryoLife (CRY) | United States | $1.123B | 111.37 |
| Accelerate Diagnostics (AXDX) | United States | $1.017B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.009B | 148.86 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.963B | 27.90 |
| ViewRay (VRAY) | United States | $0.915B | 0.00 |
| Luminex (LMNX) | United States | $0.897B | 117.35 |
| Natus Medical (BABY) | United States | $0.893B | 20.67 |
| Mesa Laboratories (MLAB) | United States | $0.878B | 41.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.814B | 0.00 |
| Fluidigm (FLDM) | United States | $0.793B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.789B | 25.84 |
| AxoGen (AXGN) | United States | $0.756B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.692B | 0.00 |
| Intersect ENT (XENT) | United States | $0.641B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.552B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.511B | 0.00 |
| Si-Bone (SIBN) | United States | $0.485B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.351B | 0.00 |
| Accuray (ARAY) | United States | $0.350B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.350B | 18.76 |
| Semler Scientific (SMLR) | United States | $0.312B | 61.99 |
| RTI Surgical (RTIX) | United States | $0.303B | 37.27 |
| TransEnterix (TRXC) | United States | $0.302B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.241B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.210B | 0.00 |
| ConforMIS (CFMS) | United States | $0.209B | 0.00 |
| IRadimed (IRMD) | United States | $0.204B | 38.89 |
| CRH Medical (CRHM) | Canada | $0.198B | 68.50 |
| Sientra (SIEN) | United States | $0.172B | 0.00 |
| Stereotaxis (STXS) | United States | $0.166B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.112B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Vermillion (VRML) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.066B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.064B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.055B | 0.00 |
